eFFECTOR Therapeutics (EFTR) Price-to-Earnings (P/E) Ratio
Price: $0.0002
Market Cap: $941
Avg Volume: 584
Market Cap: $941
Avg Volume: 584
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
eFFECTOR Therapeutics's P/E ratios across different time periods:
- TTM: 0.00
- Annual: -0.71
- Quarterly: -1.81
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: -4.41
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
eFFECTOR Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
0.00
P/B Ratio (Annual)
-4.41
P/S Ratio (Annual)
0.00
eFFECTOR Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2023 | -0.71 | -4.41 | 0.00 |
| 2022 | -1.36 | 4.52 | 4.96 |
| 2021 | 21.17 | 19.35 | 233.87 |
| 2020 | 10.48 | -1.13 | 3.55 |
| 2019 | -4.62 | -9.93 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for EFTR.